These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36053920)

  • 1. Development of a novel peptide inhibitor of subtilisin BPN'.
    Ishida K; Shimizu M; Wakasugi A; Matsui Y; Nakamura A; Kojima S
    FEBS Open Bio; 2022 Nov; 12(11):2057-2064. PubMed ID: 36053920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of subtilisin BPN' by reaction site P1 mutants of Streptomyces subtilisin inhibitor.
    Kojima S; Nishiyama Y; Kumagai I; Miura K
    J Biochem; 1991 Mar; 109(3):377-82. PubMed ID: 1908859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic studies of the inhibitory effects of propeptides subtilisin BPN' and Carlsberg to bacterial serine proteases.
    Huang HW; Chen WC; Wu CY; Yu HC; Lin WY; Chen ST; Wang KT
    Protein Eng; 1997 Oct; 10(10):1227-33. PubMed ID: 9488148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of a stabilizing Ca(2+)-binding loop into subtilisin BPN'.
    Braxton S; Wells JA
    Biochemistry; 1992 Sep; 31(34):7796-801. PubMed ID: 1510966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing subtilisin BPN' to cleave substrates containing dibasic residues.
    Ballinger MD; Tom J; Wells JA
    Biochemistry; 1995 Oct; 34(41):13312-9. PubMed ID: 7577915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The propeptide of subtilisin BPN' as a temporary inhibitor and effect of an amino acid replacement on its inhibitory activity.
    Kojima S; Minagawa T; Miura K
    FEBS Lett; 1997 Jul; 411(1):128-32. PubMed ID: 9247157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of amino acid residues responsible for the changes of absorption and fluorescence spectra on the binding of subtilisin BPN' and Streptomyces subtilisin inhibitor.
    Masuda-Momma K; Shimakawa T; Inouye K; Hiromi K; Kojima S; Kumagai I; Miura K; Tonomura B
    J Biochem; 1993 Dec; 114(6):906-11. PubMed ID: 8138550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tertiary structure formation in the propeptide of subtilisin BPN' by successive amino acid replacements and its close relation to function.
    Kojima S; Minagawa T; Miura K
    J Mol Biol; 1998 Apr; 277(5):1007-13. PubMed ID: 9571018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refined crystal structure of the complex of subtilisin BPN' and Streptomyces subtilisin inhibitor at 1.8 A resolution.
    Takeuchi Y; Satow Y; Nakamura KT; Mitsui Y
    J Mol Biol; 1991 Sep; 221(1):309-25. PubMed ID: 1920411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular recognition at the active site of subtilisin BPN': crystallographic studies using genetically engineered proteinaceous inhibitor SSI (Streptomyces subtilisin inhibitor).
    Takeuchi Y; Noguchi S; Satow Y; Kojima S; Kumagai I; Miura K; Nakamura KT; Mitsui Y
    Protein Eng; 1991 Jun; 4(5):501-8. PubMed ID: 1891457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of subtilisin BPN' and recombinant Streptomyces subtilisin inhibitors with substituted P1 site residues.
    Masuda-Momma K; Hatanaka T; Inouye K; Kanaori K; Tamura A; Akasaka K; Kojima S; Kumagai I; Miura K; Tonomura B
    J Biochem; 1993 Oct; 114(4):553-9. PubMed ID: 8276767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of a tyrosyl residue and carboxyl groups in the specific interaction between Streptomyces subtilisin inhibitor and subtilisin BPN'. A chemical modification study.
    Inouye K; Tonomura B; Hiromi K
    J Biochem; 1979 May; 85(5):1115-26. PubMed ID: 447612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of deletion in the flexible loop of the protease inhibitor SSI (Streptomyces subtilisin inhibitor) on interactions with proteases.
    Kojima S; Furukubo S; Kumagai I; Miura K
    Protein Eng; 1993 Apr; 6(3):297-303. PubMed ID: 8506264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Furilisin: a variant of subtilisin BPN' engineered for cleaving tribasic substrates.
    Ballinger MD; Tom J; Wells JA
    Biochemistry; 1996 Oct; 35(42):13579-85. PubMed ID: 8885837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel protease inhibitors via computational redesign of subtilisin BPN' propeptide.
    Daugherty AB; Muthu P; Lutz S
    Biochemistry; 2012 Oct; 51(41):8247-55. PubMed ID: 23009354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with alpha-chymotrypsin and wild-type and mutant subtilisin BPN', and protein engineering to investigate inhibitory specificity and mechanism.
    Longstaff C; Campbell AF; Fersht AR
    Biochemistry; 1990 Aug; 29(31):7339-47. PubMed ID: 2207109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of calcium-independent subtilisin BPN' with restored thermal stability folded without the prodomain.
    Almog O; Gallagher T; Tordova M; Hoskins J; Bryan P; Gilliland GL
    Proteins; 1998 Apr; 31(1):21-32. PubMed ID: 9552156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel double-headed proteinaceous inhibitor for metalloproteinase and serine proteinase.
    Hiraga K; Suzuki T; Oda K
    J Biol Chem; 2000 Aug; 275(33):25173-9. PubMed ID: 10827083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of the propeptide of subtilisin E as an intramolecular chaperone for protein folding. Refolding and inhibitory abilities of propeptide mutants.
    Li Y; Hu Z; Jordan F; Inouye M
    J Biol Chem; 1995 Oct; 270(42):25127-32. PubMed ID: 7559646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the C-terminal region of yeast proteinase B inhibitor 2 in its inhibitory action.
    Kojima S; Deguchi M; Miura K
    J Mol Biol; 1999 Feb; 286(3):775-85. PubMed ID: 10024450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.